EDEN INNOVATIONS LTD — Share Issue/Capital Change 2024

Dec 12, 2024

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Announcement Summary

Entity name

EDEN INNOVATIONS LTD

Announcement Type

New announcement

Date of this announcement

Friday December 13, 2024

The +securities to be quoted are: Other

Please refer to the response to Q2.3d for further information about the type of securities to be quoted and the circumstances of the issue.

Issue of incentive shares as agreed fee to non-executive Director, Dr Allan Larsen as detailed in Notice of Meeting dated 31 October 2024.

Total number of +securities to be quoted

ASX +security Number of +securities to code Security description be quoted Issue date EDE ORDINARY FULLY PAID 1,666,667 13/12/2024

Refer to next page for full details of the announcement

Appendix 2A - Application for quotation of securities

1 / 6

Appendix 2A - Application for quotation of securities

Part 1 - Entity and announcement details

==> picture [21 x 22] intentionally omitted <==

1.1 Name of entity

EDEN INNOVATIONS LTD

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

1.2 Registered number type

Registration number

ABN 58109200900

1.3 ASX issuer code

EDE

1.4 The announcement is

New announcement

1.5 Date of this announcement

13/12/2024

Appendix 2A - Application for quotation of securities

2 / 6

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Part 2 - Type of Issue

2.1 The +securities to be quoted are:

Other

Please refer to the response to Q2.3d for further information about the type of securities to be quoted and the circumstances of the issue.

2.2 The +class of +securities to be quoted is:

Additional +securities in a class that is already quoted on ASX ("existing class")

2.3c Have these +securities been offered under a +disclosure document or +PDS? No

2.3d Please provide any further information needed to understand the circumstances in which you are applying to have these +securities quoted on ASX, including why the issue of the +securities has not been previously announced to the market in an Appendix 3B

Issue of incentive shares as agreed fee to non-executive Director, Dr Allan Larsen as detailed in Notice of Meeting dated 31 October 2024.

2.4 Any on-sale of the +securities to be quoted within 12 months of their date of issue will comply with the secondary sale provisions in sections 707(3) and 1012C(6) of the Corporations Act by virtue of:

Not applicable - the entity has arrangements in place with the holder that ensure the securities cannot be on-sold within 12 months in a manner that would breach section 707(3) or 1012C(6)

Appendix 2A - Application for quotation of securities

3 / 6

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B

Additional +securities to be quoted in an existing class ASX +security code and description EDE : ORDINARY FULLY PAID Issue date 13/12/2024 Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class? Yes Issue details Number of +securities to be quoted 1,666,667 Are the +securities being issued for a cash consideration? No Please describe the consideration being provided for the +securities Third and final tranche of incentive shares to Dr Larsen, as agreed on 2 June 2022 for services of Chief Scientist and Manager of International Business Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the +securities to be quoted 0.002000 Any other information the entity wishes to provide about the +securities to be quoted Shares are subject to voluntary escrow until 31 December 2024 and otherwise until the Company can satisfy on-sale provisions. The purpose(s) for which the entity is issuing the securities To pay for services rendered Please provide additional details Refer to Notice of Meeting dated 31 October 2024.

Appendix 2A - Application for quotation of securities

4 / 6

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Part 4 - Issued capital following quotation

Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:

The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application)

+securities subject of this application)
	Total number of
ASX +security code and description	+securities on issue
EDE : ORDINARY FULLY PAID	4,109,876,048
EDEOD : OPTION EXPIRING 11-SEP-2026	587,250,419
EDEOC : OPTION EXPIRING 28-APR-2025	313,614,981

4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)

Total number of ASX +security code and description +securities on issue

Appendix 2A - Application for quotation of securities

5 / 6

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Part 5 - Other Listing Rule requirements

5.1 Are the +securities being issued under an exception in Listing Rule 7.2 and therefore the issue does not need any security holder approval under Listing Rule 7.1? No

5.2 Has the entity obtained, or is it obtaining, +security holder approval for the issue under listing rule 7.1? Yes

5.2a Date of meeting or proposed meeting to approve the issue under listing rule 7.1

29/11/2024

Appendix 2A - Application for quotation of securities

6 / 6